This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignees: Argenx Iip Bv, New York University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1,728 
Years Active: 2022
Title: Roeland Vanhauwaert: Innovator in Therapeutic Musk Antibodies
Introduction
Roeland Vanhauwaert is a notable inventor based in Ghent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies.
Latest Patents
Vanhauwaert holds a patent for "Therapeutic Musk Antibodies." This invention relates to antibody-based molecules, including full-length antibodies, antigen-binding domains, and antibody derivatives that can bind to and activate human muscle-specific tyrosine protein kinase (MuSK). The patent also discloses methods for treating neuromuscular conditions using these MuSK antibodies.
Career Highlights
Throughout his career, Vanhauwaert has worked with prestigious institutions, including New York University and Argenx IP Bv. His work has focused on advancing therapeutic solutions for neuromuscular disorders.
Collaborations
Some of his notable coworkers include Steven J. Burden and Shohei Koide, who have contributed to the research and development of his innovative ideas.
Conclusion
Roeland Vanhauwaert's work in therapeutic musk antibodies showcases his commitment to advancing medical science and improving treatment options for neuromuscular conditions. His contributions are a testament to the impact of innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile